Related Experiment Video
Updated: Jan 13, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Ketamine-Fentanyl Versus Ketamine-Midazolam for Sedation in Children Undergoing Flexible Fiber-optic Bronchoscopy -
Gopika Ramesh1, Golla Ramakrishna1, Ketan Kumar1
1Department of Pediatrics, AIIMS Bhubaneswar, Odisha, India.
Insights
The ketamine-fentanyl combination did not significantly reduce severe cough episodes during pediatric flexible fiberoptic bronchoscopy (FOB) compared to ketamine-midazolam. Post-hoc analysis suggested a potential benefit, with no increased adverse events observed.
Area of Science:
- Pediatric Anesthesiology
- Respiratory Medicine
- Procedural Sedation
Background:
- Flexible fiberoptic bronchoscopy (FOB) is a common pediatric procedure.
- Coughing during FOB can complicate the procedure and patient recovery.
- Optimizing sedation regimens is crucial for pediatric procedural success.
Purpose of the Study:
- To compare the efficacy of ketamine-fentanyl (KF) versus ketamine-midazolam (KM) in reducing severe cough episodes during pediatric FOB.
- To evaluate the safety profile of KF compared to KM in this patient population.
Main Methods:
- A randomized controlled trial enrolled 75 children aged 6 months to 15 years undergoing FOB.
- Participants received either intravenous ketamine and fentanyl (KF group) or ketamine and midazolam (KM group).
- Video recordings were reviewed by a blinded observer to quantify severe cough episodes.
Main Results:
- The ketamine-fentanyl group showed a trend towards fewer severe cough episodes (median 1 vs. 3), but this was not statistically significant (P=0.054).
- Post-hoc analysis revealed a significantly lower frequency of severe cough episodes per minute in the KF group (P=0.008).
- No significant differences were observed in sedation depth, procedure scores, need for additional sedation, or adverse events, including bradycardia, hypotension, or apnea.
Conclusions:
- The ketamine-fentanyl combination did not achieve statistical significance in reducing severe cough episodes during pediatric FOB compared to ketamine-midazolam.
- Post-hoc findings suggest a potential benefit of ketamine-fentanyl for cough suppression.
- The KF combination was found to be safe, with no increase in adverse events.
Objectives:
To compare the number of severe cough episodes during flexible fiberoptic bronchoscopy (FOB) in children receiving intravenous (IV) ketamine and fentanyl (KF) to those receiving IV ketamine and midazolam (KM).
Methods:
A parallel-group, open-label, randomized controlled trial was conducted at a tertiary care center. Children aged 6 mo to 15 y undergoing FOB were enrolled, excluding those with anticipated difficult airway, significant respiratory compromise, hemodynamic instability, and those undergoing interventional procedures. Video recordings of the entire procedure were reviewed by a blinded observer to assess the primary outcome.
Results:
Seventy-five participants were enrolled; 38 in the KM group and 37 in the KF group. The KF group had a lower median number of severe cough episodes [1 (0-4) vs. 3 (1-6), P = 0.054], though not statistically significant. No significant differences were found in time to reach Ramsay Sedation Scale (RSS) 4, bronchoscopy scores, need for additional sedation, or adverse events. No participants developed bradycardia, hypotension, apnea, laryngospasm, or deep desaturation. Post-hoc analysis showed a lower frequency of severe cough episodes (per minute procedure time) in the KF group [0.1 (0-0.4) vs. 0.35 (0.1-0.6), P = 0.008].
Conclusions:
This RCT did not demonstrate a significant difference in severe cough episodes with the ketamine-fentanyl combination compared to ketamine-midazolam in children undergoing FOB. However, the post-hoc analysis does indicate some benefit with the use of ketamine-fentanyl. There was no increase in adverse events with the combination.
More Related Videos
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
03:02Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Stages of General Anesthesia
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...